NASDAQ · CODX

Co. – Diagnostics, Inc.

$1.85 -$0.25 (-11.91%) 1D Market open
Session Pulse Regular session 3 mentions on Mon 2 SEC filings since Mon close 8-K 4 its sector ranked 5/11 this week Full pulse →

Key Metrics

$8.14M
Market cap
P/E · TTM
$718.17K
Revenue · TTM
−$48.50M
Net income
EPS · TTM $-45.40
Dividend yield
Free cash flow −$28.99M
Beta · 1Y 1.53
EBITDA · TTM
Gross margin 45.1%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    A material event was filed (Form 8-K).

    8-K - Co-Diagnostics, Inc. (0001692415) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 27
    Offering paper hit the record (Form 424B5).

    424B5 - Co-Diagnostics, Inc. (0001692415) (Filer)

    RECEIPT: SEC FORM 424B5, TIMESTAMPED
  • Jul 27
    An insider transaction hit the record.

    Form 4s are events, not verdicts — officers, directors, and 10% owners reporting their own trades. The forms post hours before the media writes them up.

    RECEIPT: SEC FORM 4, TIMESTAMPED
  • Jul 27
    From its May 28 high, the share price fell 82%.

    Peak close $11.19 on May 28; trough close $2.04 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -82%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 26
    The stock moved +79.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 26
  • Mar 10
    The stock moved +101.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 10

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$7.74M
Enterprise value
Shares outstanding3.7M
52-wk range$0.18 – $13.54
Avg volume · 20D1.9M
Net cash
Book value / share$15.02
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNASDAQ
About Co. – Diagnostics, Inc.
IPO dateJul 12, 2017
Employees115

Co-Diagnostics Inc is a molecular diagnostics company.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S11.34
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 45.1%
Operating -6,980.3%
Net -6,753.7%
FCF -4,036.4%
ROE / ROIC -137.9% · -620.9%

Financial Health

Current ratio2.28
Quick ratio2.09
Debt / equity
Debt / EBITDA
Net cash
Working capital$5.50M

Cash Flow · TTM

Operating CF −$28.24M
Capex −$750.15K
Free cash flow −$28.99M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

-12.3
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings